UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000007353 |
|---|---|
| Receipt number | R000008564 |
| Scientific Title | A phase II neoadjuvant trial of concurrent trastuzumab and aromatase inhibitor in postmenopausal women with HER2-positive and hormone receptor-positive breast cancer. |
| Date of disclosure of the study information | 2012/02/22 |
| Last modified on | 2024/03/21 11:18:39 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2012/02/22 02:11:25 | ||
| 2 | Update | 2012/10/13 11:30:25 | ||
| 3 | Update | 2012/10/13 11:57:11 | Institutions |
|
| 4 | Update | 2024/03/21 11:18:39 | Recruitment status Date of IRB Last follow-up date |
